Naren two ya Bao

PJ-163 Oxytocin Treatment after Myocardial Infarction Promotes Cardiac Repair and Neovascularization through Activation of Multiple Pro-survival Signals(PJ028,Cardiovascular Pharmacology (Basic), Cost-health care system/DPC/Laws (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

FRS-043 Voglibose Reduces Myocardial Infarct Size via Stimulation of GLP-1 Receptors and PI3 kinase-Akt-eNOS Pathway in Rabbits(FRS9,Novel Mechanisms of Myocardial Ischemia (IHD),Featured Research Session (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

Acute effect of G-CSF on myocardial infarct size in a rabbit model of ischemia and reperfusion

OE-182 Oxytocin reduces myocardial infarct size and improves left ventricular function and remodeling through activation of Akt, VEGF, BCI-2 and Angiogenesis(Growth factor/Cytokine(01)(H),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

OE-070 Post-Infarct Treatment with an Erythropoietin-Gelatin Hydrogel Patchlmproves Cardiac Function by Activating Prosurvival Signaling and exerting Antifibrotic and Angiogenic Effects(Genetics/Genetically engineered models/Gene therapy(M),Oral Presentation(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

OJ-184 The anti-Diabetic Drug Pioglitazone Reduces Myocardial Infarct Size by Stimulating PPARγ, PI3K and Akt in Rabbits Model of Myocardial Infarction(Myocardial ischemia / reperfusion, basic / clinical(02)(IHD),Oral Presentation (Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

PJ-723 The Anti-Diabetic Drug Voglibose Reduces Myocardial Infarct Size and Improves Left Ventricular Function via Production of Glucagon-like Peptide-1 in Rabbits(Myocardial ischemia / reperfusion, basic / clinical(04)(IHD),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

PE-228 Migritol Improve Myocardial Ischemia in Type 2 Diabetic Patients with Coronary Artery Disease(Nuclear cardiology(04)(I),Poster Session(English),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)

OJ-254 Erythropoietin Drug Delivery System protects the heart against myocardial infarction through activation of Akt and angiogenesis(Growth factor/Cytokine-2(H/M), The 71st Annual Scientific Meeting of the Japanese Circulation Society)

OE-128 Pioglitazone, an Anti-Diabetic Drug, Reduces Myocardial Infarct Size via Stimulating Peroxisome Proliferator Activated Receptor-γ (PPARγ) in Rabbits Model of Myocardial Infarction(Myocardial ischemia/reperfusion, basic/clinical-1, The 71st Annual Scientific Meeting of the Japanese Circulation Society)